Multi Indocitra Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Multi Indocitra Tbk. trades at Rp530 (market cap 303B, 154.1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 37.5× Multi Indocitra Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 154.1K). Which is the better fit depends on your goals.
| MICE | TSPC | |
|---|---|---|
Market Cap | 303B | 11.36T |
Volume | 154.1K | 1.77M |
Lot | 1.54K | 17.71K |
Turnover | 81.24M | 4.61B |
Average Price | 527.17 | 2,603.9 |
Value | 81.24M | 4.61B |
Indicative Equilibrium Price | — | 2,590 |
Indicative Equilibrium Volume | — | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →